Lanreotide autogel-induced tumour shrinkage in thyrotropin-secreting pituitary macroadenomas

Clin Endocrinol (Oxf). 2011 Mar;74(3):406-8. doi: 10.1111/j.1365-2265.2010.03929.x.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / metabolism
  • Adult
  • Antineoplastic Agents / therapeutic use
  • Gels
  • Humans
  • Male
  • Middle Aged
  • Peptides, Cyclic / therapeutic use*
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Thyrotropin / metabolism*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Gels
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Thyrotropin